PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Widyanti Soewoto

Sebelas Maret University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews1 Guidelines

Latest

Everything in the corpus, newest first.

SEP 10, 2026 · REVIEW

Survival disparities in HER2-low versus HER2-positive breast cancer: a systematic review of progression-free survival and overall survival

Frontiers in Oncology

A systematic review of 10 trials with qualitative synthesis only, reporting descriptive findings about survival disparities without meta-analytic effect sizes, confidence intervals, or quantified comparisons between HER2-low and HER2-positive cohorts.

PreliminaryKristanto Yuli Yarso Wibisono Joko Wibowo Sentoso

Reported

Records identified536

Records screened after deduplicat…180

Trials included10

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support